Department of Neurology, Alzheimer Research Center, University of Groningen, University Medical Center, Groningen, Netherlands.
Department of Nuclear medicine and Molecular Imaging, University of Groningen, University Medical Center, Groningen, Netherlands.
Curr Alzheimer Res. 2018;15(13):1267-1275. doi: 10.2174/1567205015666180913102615.
We describe the phenomenon of crossed cerebellar diaschisis (CCD) in four subjects diagnosed with Alzheimer's disease (AD) according to the National Institute on Aging - Alzheimer Association (NIA-AA) criteria, in combination with 18F-FDG PET and 11C-PiB PET imaging.
18F-FDG PET showed a pattern of cerebral metabolism with relative decrease most prominent in the frontal-parietal cortex of the left hemisphere and crossed hypometabolism of the right cerebellum. 11C-PiB PET showed symmetrical amyloid accumulation, but a lower relative tracer delivery (a surrogate of relative cerebral blood flow) in the left hemisphere. CCD is the phenomenon of unilateral cerebellar hypometabolism as a remote effect of supratentorial dysfunction of the brain in the contralateral hemisphere. The mechanism implies the involvement of the cortico-ponto-cerebellar fibers. The pathophysiology is thought to have a functional or reversible basis but can also reflect in secondary morphologic change. CCD is a well-recognized phenomenon, since the development of new imaging techniques, although scarcely described in neurodegenerative dementias.
To our knowledge this is the first report describing CCD in AD subjects with documentation of both 18F-FDG PET and 11C-PiB PET imaging. CCD in our subjects was explained on a functional basis due to neurodegenerative pathology in the left hemisphere. There was no structural lesion and the symmetric amyloid accumulation did not correspond with the unilateral metabolic impairment.
This suggests that CCD might be caused by non-amyloid neurodegeneration. The pathophysiological mechanism, clinical relevance and therapeutic implications of CCD and the role of the cerebellum in AD need further investigation.
我们根据美国国家老龄化研究所-阿尔茨海默病协会(NIA-AA)的标准,结合 18F-FDG PET 和 11C-PiB PET 成像,描述了 4 名被诊断为阿尔茨海默病(AD)的患者中交叉小脑 diaschisis(CCD)的现象。
18F-FDG PET 显示出大脑代谢模式,左侧额顶叶皮质的相对减少最为明显,右侧小脑交叉代谢低下。11C-PiB PET 显示出对称的淀粉样蛋白堆积,但左侧的相对示踪剂输送(相对脑血流的替代物)较低。CCD 是一种单侧小脑代谢低下的现象,是对侧大脑半球上矢状窦功能障碍的远程效应。该机制暗示皮质 - 桥脑 - 小脑纤维的参与。病理生理学被认为具有功能性或可逆性基础,但也可以反映在继发性形态变化中。自从新的成像技术发展以来,CCD 是一种公认的现象,尽管在神经退行性痴呆中很少描述。
据我们所知,这是首次描述 AD 患者 18F-FDG PET 和 11C-PiB PET 成像的 CCD 的报告。我们研究对象中的 CCD 是基于左半球神经退行性病变的功能基础来解释的。没有结构损伤,对称的淀粉样蛋白堆积与单侧代谢损伤不对应。
这表明 CCD 可能是由非淀粉样蛋白神经退行性变引起的。CCD 的病理生理机制、临床意义和治疗意义以及小脑在 AD 中的作用需要进一步研究。